Mechanisms of multidrug resistance and implications for therapy - PubMed (original) (raw)
Review
Mechanisms of multidrug resistance and implications for therapy
T Tsuruo. Jpn J Cancer Res. 1988 Mar.
No abstract available
Similar articles
- [Multidrug resistance of malignant tumors].
Bak M. Bak M. Orv Hetil. 1991 Oct 6;132(40):2187-92. Orv Hetil. 1991. PMID: 1682863 Review. Hungarian. - Multidrug resistance: mechanism and therapy.
Chabner BA. Chabner BA. Jpn J Cancer Res. 1993 Dec;84(12):inside front cover. Jpn J Cancer Res. 1993. PMID: 8294209 Review. No abstract available. - The multidrug resistance phenotype.
Kaye SB. Kaye SB. Br J Cancer. 1988 Dec;58(6):691-4. doi: 10.1038/bjc.1988.291. Br J Cancer. 1988. PMID: 3066393 Free PMC article. Review. No abstract available. - Multidrug resistance in the laboratory and clinic.
Kane SE, Gottesman MM. Kane SE, et al. Cancer Cells. 1989 Sep;1(1):33-6. Cancer Cells. 1989. PMID: 2701361 Review. No abstract available. - Multidrug resistance in cancer.
[No authors listed] [No authors listed] Lancet. 1989 Nov 4;2(8671):1075-6. Lancet. 1989. PMID: 2572800 Review. No abstract available.
Cited by
- P-glycoprotein expression in treated and untreated human breast cancer.
Schneider J, Bak M, Efferth T, Kaufmann M, Mattern J, Volm M. Schneider J, et al. Br J Cancer. 1989 Dec;60(6):815-8. doi: 10.1038/bjc.1989.372. Br J Cancer. 1989. PMID: 2574987 Free PMC article. - Reversal of multidrug resistance by an immunosuppressive agent FK-506.
Naito M, Oh-hara T, Yamazaki A, Danki T, Tsuruo T. Naito M, et al. Cancer Chemother Pharmacol. 1992;29(3):195-200. doi: 10.1007/BF00686252. Cancer Chemother Pharmacol. 1992. PMID: 1370765 - Uptake and intracellular distribution of amrubicin, a novel 9-amino-anthracycline, and its active metabolite amrubicinol in P388 murine leukemia cells.
Yamaoka T, Hanada M, Ichii S, Morisada S, Noguchi T, Yanagi Y. Yamaoka T, et al. Jpn J Cancer Res. 1999 Jun;90(6):685-90. doi: 10.1111/j.1349-7006.1999.tb00801.x. Jpn J Cancer Res. 1999. PMID: 10429662 Free PMC article. - Molecular targeting therapy of cancer: drug resistance, apoptosis and survival signal.
Tsuruo T, Naito M, Tomida A, Fujita N, Mashima T, Sakamoto H, Haga N. Tsuruo T, et al. Cancer Sci. 2003 Jan;94(1):15-21. doi: 10.1111/j.1349-7006.2003.tb01345.x. Cancer Sci. 2003. PMID: 12708468 Free PMC article. Review. - Quantitative analysis of human multidrug resistance 1 (MDR1) gene expression by nonisotopic competitive reverse transcriptase polymerase chain reaction assay.
Kobayashi H, Takemura Y, Miyachi H, Kawabata M, Mori S, Kawai Y, Furihata K, Sekiguchi S, Watanabe K. Kobayashi H, et al. J Clin Lab Anal. 1997;11(5):258-66. doi: 10.1002/(SICI)1098-2825(1997)11:5<258::AID-JCLA4>3.0.CO;2-3. J Clin Lab Anal. 1997. PMID: 9292393 Free PMC article.
References
- ) Biedler , J. L. and Peterson , R. H. F.Altered plasma membrane glyco‐conjugates of Chinese hamster cells with acquired resistance to actinomycin D, daunorubicin and vincristine . In “ Molecular Actions and Targets for Cancer Chemotherapeutic Agents ,” ed. Sartorelli A. C. , Lazo J. S. and Bertino J. R. , pp. 453 – 482 ( 1981. ). Academic Press; , New York .
- ) Ling , V.Genetic basis of drug resistance in mammalian cells . In “ Drug and Hormone Resistance in Neoplasia ,” Vol. 1 , ed. Bruchovsky N. and Goldie J. H. , pp. 1 – 19 ( 1983. ). CRC Press; , Miami .
- ) Chabner , B. A. , Clendeninn , N. J. and Curt , G. A.Symposium on cellular resistance to anticancer drugs . Cancer Treat. Rep. , 67 , 855 – 932 ( 1983. ). - PubMed
- ) Sugimoto , Y. and Tsuruo , T.Development of multidrug resistance in rodent cell lines . In “ Molecular and Cellular Biology of Multidrug Resistance in Tumor Cells ,” ed. Roninson I. B. ( 1988. ). Plenum Press; , New York , in press .
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources